ReviewJournal of the National Medical Association2005
Managing cardiovascular risk in minority patients.
Review in Journal of the National Medical Association, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies.Journal of clinical hypertension (Greenwich, Conn.) · 2007Trial
- Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement.American journal of preventive cardiology · 2021Article
- Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.Hypertension (Dallas, Tex. : 1979) · 2016Article
- Methods for estimation of disparities in medication use in an observational cohort study: results from the Multi-Ethnic Study of Atherosclerosis.Pharmacoepidemiology and drug safety · 2013Article
- Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia.International journal of endocrinology · 2013Article
- Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus.Experimental diabetes research · 2012Article
- Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes.The American journal of gastroenterology · 2009Article
- A coronary heart disease risk score based on patient-reported information.The American journal of cardiology · 2007Article
- The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?Journal of clinical hypertension (Greenwich, Conn.) · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the United States, large and growing minority populations, including African Americans, Hispanic Americans and South Asians, are highly susceptible to the development of cardiovascular disease. Compared with Americans of other ancestries, these populations exhibit a higher prevalence of a number of risk factors, such as dyslipidemia, hypertension, obesity and diabetes mellitus. The clustering of risk factors in these groups is also greater than in white populations. Despite the considerable burden imposed by cardiovascular disease, African Americans, Hispanic Americans and South Asians remain inadequately targeted for risk-reduction strategies, including screening and treatment for dyslipidemia. In addition, these groups have traditionally been underrepresented in trials of lipid-modifying therapy. Large, ongoing epidemiologic and clinical trials will add to our knowledge of cardiovascular risk in these minority populations and contribute to recommendations to improve risk management.
Indexed as
Identifiers
15868766PMC2568747What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.